NCT06210919View on ClinicalTrials.gov

Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

December 10, 2024

Study Completion Date

March 28, 2025

Conditions
Atrophic Scar
Interventions
BIOLOGICAL

TRTP-101

Intradermal injection of the each of four sites

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

CellinCells
All Listed Sponsors
lead

CellinCells

INDUSTRY

NCT06210919 - Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars | Biotech Hunter | Biotech Hunter